Upadacitinib | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Upadacitinib

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

28 API Suppliers, 10 USDMF, 6 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

65 Drugs in Development

65 Drugs in Development

INTERMEDIATES

31 Intermediate Suppliers

31 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

35 FDF Dossiers, 6 FDA Orange Book, 1 Europe, 3 Canada, 24 Australia, 1 South Africa

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 134 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

5 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

100 US Patents, 20 US Exclusivities

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

5 All

01 5Rinvoq

List of Suppliers

Product Main Page

01

Brand Name : Rinvoq

Immuno-Oncology 360

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Upadacitinib

Main Therapeutic Indication : Immunology

Currency : USD

2020 Revenue in Millions : 731

2019 Revenue in Millions : 47

Growth (%) : 1,455

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Rinvoq

Immuno-Oncology 360

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Upadacitinib

Main Therapeutic Indication : Immunology

Currency : USD

2021 Revenue in Millions : 1,651

2020 Revenue in Millions : 731

Growth (%) : 126

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Rinvoq

Immuno-Oncology 360

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Upadacitinib

Main Therapeutic Indication : Immunology

Currency : USD

2022 Revenue in Millions : 2,522

2021 Revenue in Millions : 1,651

Growth (%) : 53

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Rinvoq

Immuno-Oncology 360

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Upadacitinib

Main Therapeutic Indication : Immunology

Currency : USD

2023 Revenue in Millions : 3,969

2022 Revenue in Millions : 2,522

Growth (%) : 57

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Rinvoq

Immuno-Oncology 360

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Upadacitinib

Main Therapeutic Indication : Immunology

Currency : USD

2019 Revenue in Millions : 47

2018 Revenue in Millions : 0

Growth (%) : New launch

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info